Conclusions	O

Only	O
after	O
careful	O
consideration	O
of	O
the	O
biological	O
underpinnings	O
of	O
a	O
truly	O
beneficial	O
response	O
can	O
an	O
exposure	O
be	O
considered	O
for	O
the	O
general	O
population	O
,	O
such	O
as	O
the	O
addition	O
of	O
folic	O
acid	O
to	O
cereals	O
.	O

If	O
a	O
toxic	O
or	O
hazardous	O
pollutant	O
were	O
found	O
to	O
have	O
truly	O
beneficial	O
effects	O
at	O
low	O
dose	O
,	O
then	O
that	O
agent	O
should	O
be	O
tested	O
clinically	O
,	O
go	O
through	O
the	O
U	O
.	O
S	O
.	O

Food	O
and	O
Drug	O
Administration	O
(	O
FDA	O
)	O
approval	O
process	O
,	O
and	O
be	O
regulated	O
as	O
a	O
pharmaceutical	O
for	O
those	O
who	O
might	O
benefit	O
from	O
its	O
use	O
.	O

Certainly	O
,	O
the	O
general	O
population	O
should	O
not	O
be	O
exposed	O
to	O
chemotherapeutic	O
agents	O
that	O
benefit	O
cancer	B-Cancer
patients	O
.	O

For	O
pharmaceuticals	O
,	O
it	O
is	O
understood	O
that	O
there	O
are	O
trade	O
offs	O
between	O
benefits	O
and	O
risks	O
.	O

For	O
example	O
,	O
although	O
aspirin	O
is	O
a	O
generally	O
well	O
-	O
tolerated	O
pain	O
reliever	O
and	O
is	O
increasingly	O
advocated	O
as	O
a	O
preventative	O
tool	O
for	O
heart	B-Organ
attacks	O
and	O
colorectal	B-Cancer
cancer	I-Cancer
(	O
Vainio	O
and	O
Miller	O
2003	O
;	O
Werner	O
et	O
al	O
.	O
2004	O
)	O
,	O
it	O
is	O
also	O
linked	O
to	O
increased	O
risk	O
of	O
gastrointestinal	B-Organism_subdivision
bleeding	O
,	O
cerebral	B-Organ
hemorrhage	O
(	O
Werner	O
et	O
al	O
.	O
2004	O
)	O
,	O
and	O
asthma	O
attacks	O
(	O
Jenkins	O
et	O
al	O
.	O
2004	O
)	O
.	O

In	O
addition	O
,	O
aspirin	O
is	O
not	O
recommended	O
for	O
children	O
or	O
teenagers	O
who	O
have	O
or	O
are	O
recovering	O
from	O
chicken	O
pox	O
or	O
flulike	O
symptoms	O
because	O
it	O
can	O
cause	O
debilitating	O
and	O
sometimes	O
lethal	O
Reyes	O
syndrome	O
(	O
U	O
.	O
S	O
.	O
FDA	O
2003	O
)	O
.	O

Individual	O
risks	O
to	O
pharmaceutical	O
agents	O
can	O
be	O
controlled	O
with	O
proper	O
usage	O
;	O
however	O
,	O
increased	O
exposure	O
to	O
environmental	O
toxins	O
presents	O
additional	O
involuntary	O
risks	O
for	O
the	O
general	O
population	O
.	O

Under	O
the	O
latter	O
condition	O
,	O
exposure	O
is	O
inadequately	O
controlled	O
,	O
and	O
there	O
is	O
no	O
mechanism	O
to	O
correct	O
for	O
individual	O
circumstances	O
(	O
e	O
.	O
g	O
.	O
,	O
medical	O
condition	O
or	O
age	O
)	O
that	O
may	O
result	O
in	O
harm	O
.	O

Although	O
hormetic	O
effects	O
may	O
occur	O
in	O
some	O
instances	O
,	O
it	O
is	O
indeed	O
rare	O
that	O
exposures	O
to	O
toxic	O
,	O
mutagenic	O
,	O
teratogenic	O
,	O
and	O
carcinogenic	O
chemicals	O
,	O
even	O
at	O
low	O
exposure	O
levels	O
,	O
would	O
be	O
risk	O
free	O
and	O
provide	O
health	O
benefits	O
for	O
the	O
general	O
public	O
.	O

Portraying	O
chemicals	O
with	O
numerous	O
adverse	O
effects	O
as	O
having	O
benefits	O
while	O
ignoring	O
their	O
hazards	O
is	O
irresponsible	O
and	O
does	O
not	O
provide	O
full	O
and	O
objective	O
disclosure	O
.	O

In	O
the	O
1950s	O
doctors	O
prescribed	O
DES	O
to	O
pregnant	O
women	O
to	O
prevent	O
miscarriage	O
and	O
premature	O
births	O
and	O
to	O
produce	O
"	O
bigger	O
and	O
stronger	O
babies	O
"	O
even	O
though	O
DES	O
had	O
been	O
shown	O
to	O
cause	O
damage	O
to	O
reproductive	O
tissues	B-Tissue
in	O
animals	O
(	O
Dinusson	O
et	O
al	O
.	O
1948	O
;	O
Dunn	O
and	O
Green	O
1963	O
;	O
Takasugi	O
and	O
Bern	O
1964	O
)	O
.	O

Human	O
use	O
of	O
DES	O
was	O
banned	O
in	O
the	O
United	O
States	O
in	O
1971	O
after	O
the	O
discovery	O
of	O
high	O
rates	O
of	O
rare	O
,	O
clear	O
-	O
cell	O
adenocarcinomas	B-Cancer
of	O
the	O
vagina	B-Multi-tissue_structure
and	O
cervix	B-Multi-tissue_structure
in	O
DES	O
-	O
exposed	O
daughters	O
(	O
Herbst	O
1981	O
)	O
,	O
and	O
later	O
studies	O
showed	O
elevated	O
breast	B-Cancer
cancer	I-Cancer
risk	O
in	O
women	O
who	O
took	O
DES	O
during	O
pregnancy	O
(	O
Titus	O
-	O
Ernstoff	O
et	O
al	O
.	O
2001	O
)	O
.	O

Certainly	O
,	O
health	O
policy	O
decisions	O
should	O
be	O
based	O
on	O
scientific	O
evidence	O
and	O
not	O
on	O
speculation	O
of	O
health	O
benefits	O
in	O
order	O
for	O
the	O
general	O
population	O
to	O
avoid	O
repeating	O
the	O
mistakes	O
of	O
the	O
past	O
similar	O
to	O
that	O
of	O
the	O
DES	O
tragedy	O
.	O

The	O
claims	O
and	O
projections	O
of	O
health	O
benefits	O
from	O
exposures	O
to	O
environmental	O
toxicants	O
and	O
carcinogens	O
are	O
based	O
on	O
untested	O
assumptions	O
and	O
disregard	O
numerous	O
well	O
-	O
established	O
scientific	O
principles	O
that	O
underpin	O
a	O
public	O
health	O
-	O
protective	O
approach	O
to	O
regulating	O
exposure	O
to	O
toxic	O
substances	O
.	O

If	O
hormesis	O
were	O
used	O
in	O
the	O
decision	O
-	O
making	O
process	O
to	O
allow	O
higher	O
exposures	O
to	O
toxic	O
and	O
carcinogenic	O
agents	O
,	O
this	O
would	O
substantially	O
increase	O
health	O
risks	O
for	O
many	O
,	O
if	O
not	O
most	O
,	O
segments	O
of	O
the	O
general	O
population	O
.	O

